During the past decade, Research Center for Clinical Studies, Inc. conducted 19 clinical trials. In the 10-year time frame, 19 clinical trials started and 15 clinical trials were completed, i.e. on average, 78.9% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 8 clinical trials were completed. i.e. 133.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Research Center for Clinical Studies, Inc." #1 sponsor was "Hoffmann-La Roche" with 6 trials, followed by "Biogen" with 3 trials sponsored, "JANSSEN Alzheimer Immunotherapy Research & Development, LLC" with 3 trials sponsored, "Pfizer" with 3 trials sponsored and "Eisai Inc." with 3 trials sponsored. Other sponsors include 14 different institutions and companies that sponsored additional 21 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Research Center for Clinical Studies, Inc." #1 collaborator was "Pfizer" with 4 trials as a collaborator, "National Institute on Aging (NIA)" with 2 trials as a collaborator, "Alzheimer's Association" with 1 trials as a collaborator, "Alzheimer's Disease Cooperative Study (ADCS)" with 1 trials as a collaborator and "Biogen" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 9 trials.

According to Clinical.Site data, the most researched conditions in "Research Center for Clinical Studies, Inc." are "Alzheimer's Disease" (20 trials), "Alzheimer Disease" (9 trials), "Agitation in Patients With Dementia of the Alzheimer's Type" (2 trials), "Aggression" (1 trials) and "Agitation" (1 trials). Many other conditions were trialed in "Research Center for Clinical Studies, Inc." in a lesser frequency.

Most popular intervention types in "Research Center for Clinical Studies, Inc." are "Drug" (36 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (17 trials), "Bapineuzumab 0.5 mg/kg" (3 trials), "Crenezumab" (3 trials), "AVP-786" (2 trials) and "Aducanumab" (2 trials). Other intervention names were less common.

The vast majority of trials in "Research Center for Clinical Studies, Inc." are 36 trials for "All" genders.

Currently, there are NaN active trials in "Research Center for Clinical Studies, Inc.". undefined are not yet recruiting, 2 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 18 completed trials in Research Center for Clinical Studies, Inc., undefined suspended trials, and 12 terminated clinical trials to date.

Out of the total trials that were conducted in Research Center for Clinical Studies, Inc., 0 "Phase 1" clinical trials were conducted, 9 "Phase 2" clinical trials and 24 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 0 trials that are defined as “Not Applicable".